| 吡柔比星为主联合方案治疗晚期乳腺癌46例临床分析 |
| |
| 引用本文： | 庄晓文,陈蕾,詹德文.吡柔比星为主联合方案治疗晚期乳腺癌46例临床分析[J].中国肿瘤临床与康复,2001,8(6):75-76. |
| |
| 作者姓名： | 庄晓文 陈蕾 詹德文 |
| |
| 作者单位： | 汕头大学医学院肿瘤医院内科,广东,515031 |
| |
| 摘 要： | 目的应用吡柔比星为主联合化疗方案治疗晚期乳腺癌,评价其有效性及毒性.方法46例晚期乳腺癌患者应用吡柔比星为主联合方案2～6周期.结果本治疗组有效率47.8%,毒性反应低.结论吡柔比星为主联合方案适合治疗晚期乳腺癌患者,毒性低,值得临床应用.
|
| 关 键 词： | 吡柔比星 联合化疗 乳腺癌 |
| 文章编号： | 1005-8664(2001)06-0075-02 |
| 修稿时间： | 2001年4月30日 |
Chemotherapy with THP-containing regimen for the treatment of advanced breast cancer: a clinical study of 46 cases |
| |
| ZHUANG Xiao wen,CMEN Lei,ZHAN De wen.Chemotherapy with THP-containing regimen for the treatment of advanced breast cancer: a clinical study of 46 cases[J].Chinese Journal of Clinical Oncology and Rehabilitation,2001,8(6):75-76. |
| |
| Authors: | ZHUANG Xiao wen CMEN Lei ZHAN De wen |
| |
| Institution: | ZHUANG Xiao wen,CMEN Lei,ZHAN De wen. Department of Internal Medicine,Affiliated Tumor Hospital,Shantou University Medical College,Shantou 515031,China |
| |
| Abstract: | Objective To evaluate efficacy and toxicity of THP containing regimen in the treatment of advanced breast cancer.Methods 46 patients with advanced breast cancer were treated by chemotherapeutic regimens mainly containing THP for 2 to 6 cycles.Results The response rate was 47.8% and toxicity was mild.Conclusion Our results suggest that THP containing regimen is an active regimen for patients with advanced breast cancer with low toxicity and worthy of being widely used in the clinical. |
| |
| Keywords: | pirarubicin (THP) combined chemotherapy breast cancer |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
